SCHEMBL1009799

SCHEMBL1009799

C=CC(=O)OC[Si](C)(C)O[SiH](O[Si](C)(C)COC(=O)C=C)C(C)C[Si](OC(=C)C)(OC(=C)C)OC(=C)C

nearest known ligand 0.36

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5872008 0.79 TSHR (0.40) TSHR
SCHEMBL5872423 0.73 TSHR (0.33) TSHR
SCHEMBL6376410 0.73 TSHR (0.33) TSHR
SCHEMBL5406656 0.69 TSHR (0.42) TSHR
SCHEMBL5069823 0.69 TSHR (0.45) TSHR
SCHEMBL231327 0.68 TSHR (0.50) TSHR
SCHEMBL5839203 0.67 TSHR (0.46) TSHR
SCHEMBL332972 0.67 TSHR (0.47) TSHR
SCHEMBL5395142 0.66 TSHR (0.42) TSHR
SCHEMBL107384 0.65 TSHR (0.45) TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1201672-B1 Organosilicon compound SHINETSU CHEMICAL CO (JP) 2011-01-05 EP disclosed
US-7045572-B2 Organosilicon compound SHIN-ETSU CHEMICAL CO., LTD. (JP) 2006-05-16 US disclosed
US-20050101791-A1 Organosilicon compound SHIN-ETSU CHEMICAL CO., LTD. (JP) 2005-05-12 US disclosed
US-6849755-B2 Organosilicon compound SHIN-ETSU CHEMICAL CO., LTD. (JP) 2005-02-01 US disclosed
US-20020099232-A1 Organosilicon compound SHIN-ETSU CHEMICAL CO., LTD. (JP) 2002-07-25 US disclosed
EP-1201672-A2 Organosilicon compound SHIN-ETSU CHEMICAL CO., LTD. (JP) 2002-05-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050101791-A1 Organosilicon compound H1-0, H1-2, H1-4 TSHR 2447/4885
US-20020099232-A1 Organosilicon compound H1-0, H1-4, H1-2 TSHR 3723/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.